Didier Hagenauer

Director Clinical Development

Didier has more than 25 years of experience in clinical development, bringing extensive international experience in Medical Affairs in oncology and hematology from various companies, including AstraZeneca. He joins Priothera from Glycostem Therapeutics, a clinical stage company involved in the development of immunotherapy products for acute myelogenous leukemia, where he was Chief Medical Officer. Prior to that, Didier was at Kiadis Pharma, a European biopharmaceutical company, where he led the clinical development program of the Company’s lead program, an adjuvant therapy for hematopoietic stem cell transplantation in various leukemias and genetic diseases. Didier graduated as a Medical Doctor from the University of Paris, France and obtained his Business Administration degree from ESSEC, Paris.